INDUSTRY SYMPOSIA

Thursday October 21

8:50

From the crossing to the treatment: modern devices for different stages

Speaker: Eric Ducasse

  • No mortality increase with paclitaxel coated devices in lower limb arterial interventions – an interim analysis of SWEDEPAD RCT data. Joakim Nordanstig
  • Rotarex use in in-stent and bypass occlusion. Bruno Migliara

11:10

From vessel preparation to stenting : stay active!

  • Vessel preparation : an essential step to optimize your results. Gilles Goyault
  • Atherectomy : how and why JETSTREAM™ is the tool of choice in vessel preparation. The contribution of the imagery in the preparation of the vessel. Nicolas Louis
  • Let’s stay active : update on stenting and place of paclitaxel. What’s new in the landscape of clinical studies on the subject? Yann Gouëffic

12:00

Endovascular treatment of common femoral artery occlusive lesions.
The key role of the Supera™ stent

Moderator: Koen Deloose

  • Introduction : State of the art of CFA surgery treatment.
    The new role of endo technics et the role of the Supera.
    Raphaël Coscas
  • Results of Endovascular Endo CFA treatment technics, through clinical cases
    Wouter Lansink

2:40

Roadsaver : The Power of facts

Speaker: Koen Deloose

  • Introduction & Guideline
  • Patient Selection
  • Dual Layer Mesh technology & case presentation
  • Results of the latest clinical publication

4:00


  • Not every PAU has to be treated with an EVAR device. Nikolaos Tsilimparis
  • Finally towards on-label use of bridging stentgrafts in FEVAR: update of the BeGraft multicenter prospective study. Eric Verhoeven

5:40

Penumbra´s innovative solutions for Embolisation and Thrombectomy

Thursday October 21

1:15

ESKD Lunch symposium (lunch boxes will be distributed onsite)

  • Multidisciplinary expert panel: discussing the holistic approach to arteriovenous graft and fistula, José Ibeas and the Panel
  • Updates on the WavelinQ™ EndoAVF global clinical program, Panagiotis M. Kitrou
  • Recorded case with WavelinQ™ EndoAVF, Ounali Jaffer
  • Recorded case with WavelinQ™ EndoAVF, K Panagiotis M. Kitrou
  • Secondary cases on an EndoAVF with coiling and ballooning, Tobias Steinke
  • Role of mechanical thrombectomy for restoring dialysis access. Arterio-venous graft recorded case, Samuel Heller
  • Questions and answers, Raphaël Coscas and Alexandros Mallios

Friday October 22

8:40

The role of external stenting in prevention of vein graft disease
Alexandros Mallios

9:20

Straight talk from the experts: Examining challenges and controversies in the treatment of long complex peripheral disease
Moderator: Yann Goueffic

Treatment of PAD with endoluminal bypass in long de novo lesions and in-stent restenosis with the Gore® Viabhan® endoprosthesis: Review of cases

  • De novo lesions clinical cases, Raphaël Coscas
  • Intra-stent restenosis clinical cases, Bahaa Nasr

11:30

Proven design for an off the shelf TAAA graft

  • Introduction and Moderator Bijan Modarai
  • How technical features can make a difference, Jonathan Sobocinski
  • Making complex easier for the emergent setting, Martin Austermann
  • Q&A

12:30

Why does aneurysm sac regression matter and how can ESAR improve the outcomes?
Moderator: Jean-Pierre Becquemin

  • Factors influencing sac remodeling : are all stentgrafts equal? Jean-Pierre Becquemin
  • Improve the sealing zone thanks to ESAR : when, how, what proof of efficacy? Antoine Million
  • How to get the best out of ESAR technique? Nicolas Valerio

3:00


Truly minimally invasive peripheral interventions – tips and benefits of staying 4F

3:20


Could closure devices help develop ambulatory activities?
Moderators: Eric Ducasse & Yann Gouëffic
Speaker: Laurent Casbas

  • Official recommendations for ambulatory activities
  • The patient ambulatory path in my clinic
  • Vascular closure devices and ambulatory activity

4:20


See clearly – Treat optimally

Moderator: Koen Deloose

  • How to define a calcified lesion? Fabrizio Fanelli
  • Rotational or laser atherectomy indications? Theodosios Bisdas
  • Contribution of IVUS in crossing CTO, Jérôme Brunet
  • Discussion